Reading Time: 2 minutesIntroduction Diabetes mellitus, a chronic metabolic disorder, affects millions of American males, necessitating advanced therapeutic strategies to manage blood glucose levels effectively. Among the arsenal of treatments, semaglutide and insulin have emerged as pivotal players. This article delves into the nuanced interplay between these two agents, examining whether their roles are complementary or competitive in the management of diabetes. Understanding Semaglutide Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has revolutionized diabetes care with its once-weekly dosing and potent glucose-lowering effects. It mimics the incretin hormone, enhancing insulin secretion, suppressing glucagon release, and promoting satiety, which can lead to weight loss—an … Continue reading →